Related by context. All words. (Click for frequent words.) 67 Histologic 66 gadolinium enhanced 66 Figure 1C 65 hyperintensity 64 T2 lesions 64 LV ejection fraction 63 FDG uptake 63 F FLT 63 T2 weighted images 63 lumbar spine BMD 63 ischemic lesions 63 trabecular 62 specific alkaline phosphatase 62 microvessel density 62 distal femoral 62 immunostaining 62 TRUS 62 hip BMD 62 fractional shortening 62 parenchymal 61 morphometric vertebral fractures 61 T1 weighted 61 NMIBC 61 Immunohistochemical staining 61 T2 weighted 61 hematoxylin eosin original 61 creatine kinase MB 61 diffusion tensor 61 Histopathologic 61 hypointense 61 TUNEL 61 biochemical recurrence 61 HRCT 61 transcranial Doppler ultrasound 61 PSA nadir 61 hyperintensities 61 transcranial Doppler 61 interobserver 61 FDG-PET/CT 61 pulmonary metastases 61 immunoreactivity 60 morphologic characteristics 60 Fig. 1D 60 TURBT 60 gadolinium enhancing lesions 60 ml min 60 atheroma volume 60 RARP 60 tumor xenograft models 60 TIMP 60 F FDG PET 60 quantitative computed tomography 60 biopsy Gleason 60 T2 lesion volume 60 myocardial necrosis 60 tracer uptake 60 transabdominal 60 prostate carcinoma 60 ultrasonographic 60 electrocardiographic 60 ischemia driven 60 pT2 60 lumbar spine bone 59 thyroglobulin 59 hilar 59 surgically resected 59 extracapsular extension 59 carboxypeptidase 59 Tomographic 59 % Confidence Interval 59 NTx 59 lymphovascular invasion 59 immunohistochemical analysis 59 CD# expression [001] 59 Fig. 3b 59 mitral annular 59 peritumoral 59 radiotherapy RT 59 erythrocyte sedimentation rate 59 fig. S2 59 Intracranial 59 Endometrial 59 grade squamous intraepithelial 59 pT3 59 Hazard Ratio HR 59 -#.# ± [002] 59 lumen diameter 59 μg ml 59 Am J Cardiol 59 urothelial 59 p# antigen 59 Computed tomographic 59 cardiac perfusion 59 mRNA encoding 59 microvessel 59 computed tomographic angiography 59 mRNA expression 59 intratumoral 59 colorectal adenoma 59 transthoracic echocardiography 59 #.#/#.# mm Hg [003] 59 histopathologic examination 59 λ 59 CR nPR 59 T3 T4 59 hypervascular 59 WOMAC pain 59 lactate dehydrogenase 59 lactate dehydrogenase LDH 59 XIENCE V demonstrated 59 Gastrointestinal Stromal Tumors 59 sonographically 59 hemoglobin Hb 58 Index CDAI 58 radical prostatectomy RP 58 χ 58 hepatic insulin sensitivity 58 preoperative PSA 58 baseline FEV 58 detrusor 58 serum TSH 58 XIENCE V PROMUS Stent 58 FDG PET imaging 58 T1 weighted images 58 T1 hypointense lesions 58 superficial femoral 58 P = .# 58 femoral neck BMD 58 proximal tibial 58 Î ¼ 58 Radiographic 58 seminal vesicle invasion 58 left ventricular diastolic 58 lymph node metastasis 58 diastolic velocity 58 reactive hyperemia 58 uM 58 Figure 1A 58 ventricular myocardium 58 biochemical relapse 58 Intramedullary 58 ^ sup #m 58 transvaginal sonography 58 antral 58 μmol L 58 intraventricular 58 inflammatory lesions 58 hyperplastic 58 postop 58 transmural 58 cytokeratin 58 lesional 58 Color Doppler 58 hemodynamically significant 58 deoxy 58 #F FDG 58 polypoid 58 J Am Soc 58 PASI scores 58 RFLP 58 Supplemental Figure 58 NIHSS 58 rs# [004] 58 Crohn Disease Activity 58 adenoma recurrence 58 tissue oxygenation 58 endometrioid 58 T2 weighted MRI 58 proximal tibia 58 DU# [002] 58 Kruskal Wallis test 58 gadolinium enhancing T1 58 CD# CD# 58 D Dimer 58 serum HBV DNA 58 Pearson correlation coefficient 58 splenic 58 ascending aortic 58 neointimal 58 PaO 2 58 umbilical vein 58 Mammographic 58 TIMP 1 58 pmol L 58 immunofluorescence staining 58 Peripheral Arterial 58 urinary N telopeptide 58 endometrial thickness 57 -# dBc [002] 57 Ki# 57 mediated dilation 57 serum prostate 57 TAXUS Liberté stent 57 chondral 57 PSADT 57 immunoreactive 57 T2 weighted imaging 57 Visual Analog Scale 57 transthoracic 57 mL/min/#.# m 2 57 Sagittal 57 antitrypsin 57 Hypertrophy 57 splanchnic 57 bi ventricular pacing 57 QTcF 57 cellularity 57 denervation 57 epididymal 57 lymphopenia 57 serum aminotransferase levels 57 cystoscopic 57 CIN2 + 57 creatinine ratio 57 μg liter 57 interobserver reliability 57 vastus lateralis 57 serum triglycerides 57 microsatellite instability 57 hypoechoic 57 #OHD 57 ANCOVA 57 figs. 57 intraobserver 57 intrahepatic 57 HER2 expression 57 histologic findings 57 hyperintense lesions 57 pulsed Doppler 57 mediastinal 57 underwent resection 57 vitreous haze 57 demonstrated clinically meaningful 57 echogenicity 57 CDAI score 57 Eur J Endocrinol 57 ERalpha 57 Injury Severity Score 57 endoleak 57 dimensional echocardiography 57 Figure 2C 57 intact parathyroid hormone 57 Humeral 57 fig. S1 57 Supplementary Table 57 interobserver agreement 57 distal anastomosis 57 Schematic representation 57 renal cortical 57 brain parenchyma 57 intercellular adhesion molecule 57 arteriolar 57 serum cortisol 57 pN 57 intraperitoneal 57 urothelial carcinoma 57 nerve conduction velocity 57 #,# OH 57 ALT elevation 57 Papillary 57 induration 57 alveolar epithelial cells 57 Sitrans 57 ipsilateral 57 invasive carcinomas 57 Nephrol 57 dehydroepiandrosterone sulfate 57 Fig. 2A 57 DAS# CRP 57 carcinoembryonic antigen 57 extraocular 57 TRAIL R1 57 Nat Biotechnol 57 Frequency Response 57 malignant nodules 57 bioavailable testosterone 57 binary restenosis 57 ASCUS 57 intravascular hemolysis 57 Secondary endpoints included 57 F FDG uptake 56 multivariate Cox 56 diaphysis 56 nmol 56 Insertion Loss 56 leiomyomas 56 mononuclear 56 isoenzyme 56 Doppler sonography 56 SUVmax 56 antegrade 56 selectively binds 56 transurethral 56 contralateral 56 Abstract Number 56 D Stat Flowable 56 echo planar 56 #S #S [003] 56 foveal thickness 56 bronchoalveolar lavage 56 mean ± SEM 56 isoprostane 56 stent binary restenosis 56 interquartile range IQR 56 CD4 CD8 56 metaplasia 56 HDRS 56 Laser Lok 56 Histological 56 #.#/#.# mmHg [001] 56 prespecified secondary 56 distal femur 56 postoperative radiographs 56 ± SEM 56 intraluminal 56 gastroduodenal 56 Fig. 2b 56 Apolipoprotein 56 heterozygotes 56 κ 56 urography 56 Qmax 56 MR Angiography 56 Target Lesion Revascularization TLR 56 Operative mortality 56 Fig. 2B 56 choroidal neovascularization CNV 56 TOP2A gene 56 Myocardial 56 Brief Psychiatric 56 #β estradiol 56 #Gy 56 thyroid carcinoma 56 cannulated 56 myocardial infarct size 56 leukocytosis 56 mm3 56 Carotid artery 56 Foxp3 + 56 IIIb 56 LNCaP 56 CDAI 56 posttreatment 56 Preoperatively 56 Postoperative 56 afterload 56 abdominal computed tomography 56 neutrophil count 56 mCi 56 rFSH 56 brachial artery flow 56 agarose gel electrophoresis 56 pleomorphic 56 Angiographic 56 dyssynchrony 56 ADAS cog 56 Alanine 56 selective agonist 56 Left Ventricular 56 semiquantitative 56 MDCT angiography 56 bFGF 56 xenograft model 56 DCE MRI 56 peroneal 56 renal pelvis 56 preoperatively 56 p = #.# [003] 56 junctional 56 umbilical artery 56 enhanced sonography 56 interrater 56 Stomatitis 56 histopathological 56 Visual Analogue Scale VAS 56 glutamyl 56 Tie2 56 pleural fluid 56 r2 = 56 specific CD8 + 56 mm Stent 56 computed tomographic 56 Alkaline Phosphatase 56 scintigraphic 56 dose dependently 56 triiodothyronine 56 orthotopic 56 HepG2 cells 56 kg -1 56 MBq 56 fibrin deposition 56 Annexin V 56 lateral radiographs 56 femoral neck 56 calcified plaques 56 gadolinium Gd 56 aggrecan 56 lymphadenectomy 56 endoscopic ultrasonography 56 VEGFR1 56 symptomatic VTE 56 THERMOCOOL R 56 Lumbar spine 56 intima media thickness IMT 56 Beta Amyloid 56 Score DAS 56 echogenic 56 Erythema 56 L1 L2 56 EQ 5D 56 IL 1ß 56 spirometric 56 homozygotes 56 schwannomas 56 esophageal carcinoma 56 eosin 56 transcranial 56 aspartate aminotransferase 56 IFN α 56 cytolytic activity 56 P0 56 CD3 + 56 steroidogenic 56 CK # plasma concentrations 55 baseline LDH 55 cell receptor TCR 55 0D 55 azimuthal 55 acyltransferase 55 lymphocyte counts 55 Diastolic 55 rCBF 55 serum urate 55 lumbar interbody fusion 55 Fig. 1b 55 colorectal carcinoma 55 stent stenosis 55 Vertebral 55 tumor necrosis 55 osteopenic 55 Pathologic 55 cancellous 55 Tf 55 Abstract Full Text 55 CI -#.# 55 Kaplan Meier analysis 55 p ≤ 55 renal cysts 55 lymphocytosis 55 apparent diffusion coefficient 55 left ventricular LV 55 2dB 55 nmol liter 55 FOLFOX6 55 Severity Index PASI 55 #mV V 55 unfractionated heparin UFH 55 elevated transaminases 55 urodynamic 55 leukocyte count 55 Axillary 55 morphologic 55 hindfoot 55 Suppl. 55 Evaluable 55 CC genotype 55 normoxic 55 CRp 55 transesophageal echocardiography 55 proximal femoral 55 oxyhemoglobin 55 hypoperfusion 55 vitreous floaters 55 histologic subtype 55 μl 55 cm proximal 55 mIU ml 55 monophasic 55 tumor perfusion 55 mAs 55 COL#A# 55 K#N 55 null mice 55 posterolateral fusion 55 carcinoids 55 infarct size 55 Antiviral Therapy 55 Suppl 55 Mutational 55 μg L 55 plasmacytoid 55 coronary stenosis 55 transfected cells 55 serum homocysteine 55 dysuria 55 degranulation 55 intramedullary nailing 55 Immunohistochemical 55 RIGScan R 55 synovial 55 undetectable HBV DNA 55 QRS duration 55 viral titers 55 suppl. 55 Fig. 4a 55 adnexal 55 viral titer 55 postoperative hemorrhage 55 neovascular 55 Intraperitoneal 55 somatostatin analog 55 NYHA functional class 55 multivariable Cox 55 Nucleic Acids Res 55 Interferometric 55 Postoperatively 55 periocular 55 Ejection Fraction 55 axial length 55 T1 T2 55 abstr 55 corneal curvature 55 #.#Hz 55 Patency 55 mH 55 phosphorylated tau 55 intraoperative complications 55 benign neoplasms 55 digital tomosynthesis 55 mL/min/#.# m2 55 opacification 55 ε 55 mucinous 55 crossclamp 55 normal karyotype 55 transgenic mice expressing 55 Histologically 55 extracranial 55 Phospholipase 55 6MWD 55 dinucleotide 55 receiving VICTRELIS 55 transdermal estradiol 55 Median PFS 55 artery stenosis 55 PANSS 55 HGPIN 55 hepatocellular carcinomas 55 full thickness plication 55 #.#ng/ml 55 intramyocardial 55 esophagogastroduodenoscopy 55 primary patency 55 uL 55 HOUSE Remains 55 autoregulation 55 sirolimus eluting 55 osteotomies 55 TNFalpha 55 Prostate Cancer Recurrence 55 pulmonary angiography 55 neointimal hyperplasia 55 intestinal metaplasia 55 Dent Res 55 Hemodynamic 55 progression TTP 55 serum testosterone 55 computed tomographic scan 55 collagenous colitis 55 sonographically guided 55 log# copies mL 55 popliteal 55 CI #.#-#.# [001] 55 fluorodeoxyglucose positron emission tomography 55 SGRQ 55 fatty infiltration 55 tibiofemoral 55 HAQ DI 55 Fig. 1a 55 UNI XC 55 cytologic 55 CD# + [001] 55 induced platelet aggregation 55 PSA kinetics 55 tPSA 55 intravesical therapy 55 PF# [002] 55 â ‰ ¥ 55 TECNIS ® 55 -#.# log# copies mL 55 diabetes mellitus DM 55 Lesion 55 liver histology 55 Tubulin 55 ETDRS 55 murine model 55 extra articular 55 lateral radiograph 55 prostatic adenocarcinoma 55 receptor kinase 55 Visual Analog 55 ν 55 postintervention 55 intraepithelial neoplasia 55 attenuation correction 55 ng dL 55 Key secondary endpoints 55 nM 55 pulsatile flow 55 aspartate aminotransferase AST 55 AST ALT 55 mg TID 54 Quantitation 54 explants 54 Preoperative 54 statistically significant p = 54 #degreesC 54 symptomatic intracranial hemorrhage 54 intraperitoneally 54 Intraocular Pressure 54 bivalirudin monotherapy 54 HOMA IR 54 serum thyroglobulin 54 #nm wavelength [001] 54 mu m 54 Drillhole 54 homozygote 54 Inventory BPI 54 ovarian carcinoma 54 proton MR spectroscopy 54 transgene expression 54 TAXUS Express Stent 54 p = .# [002] 54 -2 -3 54 highest tertile 54 Downlink 54 % CI #.#-#.# [005] 54 obturator 54 intravascular ultrasonography 54 cisplatin resistant 54 nanomolar 54 Prognostic significance 54 urine cytology 54 functional mitral regurgitation 54 cm ² 54 WOMAC scores 54 anterolateral 54 CONDITIONAL HANDICAP 54 Leydig cell 54 #.#dB [003] 54 Disease Activity 54 choroidal 54 periprocedural MI 54 #.#-#.# [011] 54 fraction LVEF 54 MADRS score 54 variant allele 54 breast carcinomas 54 induced apoptosis 54 pretreatment baseline 54 ^ Tc 54 adrenocortical 54 KOOS 54 papillary thyroid carcinoma 54 Y BOCS 54 Cardiac Troponin 54 BPH benign prostatic 54 mL sec 54 pro brain natriuretic 54 Brief Pain 54 kVp 54 carotid IMT 54 Fig. 1B 54 hepatic enzyme 54 Lower Limb 54 periventricular 54 ± #.#mm [001] 54 μV 54 haematologic 54 tolterodine ER 54 doxorubicin cyclophosphamide 54 hyperacute 54 glucocorticoid induced 54 osteolytic lesions 54 distensibility 54 Carotid 54 nasal symptom 54 colorectal liver metastases 54 interleukin IL -# 54 AUCs 54 intraabdominal 54 colocalization 54 DLTs 54 carotid artery intima media 54 Intravascular 54 doi #.#/fj.#-# 54 ventricular dilation 54 FDG PET CT 54 collagen degradation 54 Sonographic 54 NIH CPSI 54 #CM [002] 54 mineral density BMD 54 arthrography 54 BoNT 54 contractile function 54 neutrophil counts 54 TPV r 54 timepoints 54 dI dV 54 albumin excretion rate 54 ERK activation 54 abdominal pain abdominal discomfort 54 choroidal neovascularization 54 leukocyte counts 54 ‰ ¥ 54 Tg mice 54 nonmetastatic 54 Fig. 2d 54 logMAR 54 conjunctival hyperemia 54 Pain Rating Scale 54 confidence intervals CIs 54 macrophage infiltration 54 LV dysfunction 54 intima media thickness 54 astrocytic 54 microbiological eradication 54 mitral stenosis 54 Pharmacokinetics PK 54 paraprotein 54 computed tomographic scans 54 lipoprotein Lp 54 hepatic enzymes 54 Elastography 54 min -1 54 Heterozygous 54 noncalcified 54 nodal metastases 54 Ankle Brachial Index 54 Flu Cy 54 plasma kallikrein inhibitor 54 mU liter 54 osteochondroma 54 Crystalens AO 54 photocoagulation 54 histological subtype 54 Primary endpoints 54 PEG IFN 54 μg d 54 posterior tibial 54 suppl #S 54 PO4 54 interleukin IL -6 54 polymorphonuclear 54 Intra articular 54 radiographic findings 54 Ultrasonography 54 posterior cingulate 54 ventilation perfusion 54 intracardiac 54 spherical aberrations 54 Fibromyalgia Impact Questionnaire 54 diameter stenosis 54 Figs. 54 % CI #.#-#.# [003] 54 cartilage lesions 54 secondary efficacy endpoint 54 hematoxylin 54 MATERIALS AND METHODS 54 Deadlinepix 54 Ann Oncol 54 Thrombolysis 54 aortic insufficiency 54 cortical activation 54 Supplementary Figs 54 LPS induced 54 color Doppler ultrasonography 54 CNS LS 54 central corneal thickness 54 SELENA SLEDAI 54 epicardial 54 metastatic malignant 54 serum HCV RNA 54 JETSTREAM G3 54 #m Tc 54 Infarct 54 segmentectomy 54 antiapoptotic 54 talar 54 intraocular pressure IOP 54 posterolateral 54 Fig. 1d 54 Serum concentrations 54 dimeglumine 54 intimal 54 PCWP 54 microsomal 54 mL kg 54 Kellgren Lawrence 54 serum IgG 54 specific antigen PSA 54 Prostate specific antigen 54 Nephrol Dial Transplant 54 pCR 54 biochemical marker 54 Hormone Refractory Prostate Cancer 54 protein tyrosine phosphatase 54 serum magnesium 54 univariate analysis 54 myocardial perfusion 54 HT 1A 54 Mantel Haenszel 54 Optical Spectrum Analyzer 54 covariance ANCOVA 54 Dilatation 54 lumbar lordosis 54 EBRT 54 P ≤ 54 multivariable adjusted 54 endoleaks 54 helical CT 54 multiplanar 54 IFN γ 54 regression coefficients 54 mmHg diastolic 54 HBeAg 54 myocardial reperfusion 54 pituitary adenomas 54 TT genotype 54 echocardiographic 54 CI #.#-#.# p = 54 IELT 54 Fig. 3a 54 tibial tubercle 54 Visual acuity 54 paracentesis 54 Fig. 2C 54 B Cell Lymphoma 54 macroalbuminuria 54 Myocardial Infarction TIMI 54 varus deformity 54 urine albumin 54 non menstrual pelvic 54 p = NS 54 + - Vulnerable 54 Postoperative complications 54 wavelet transform 54 subscores 54 thoracolumbar spine 53 caval 53 fig. S8 53 tortuosity 53 Annexin 53 underwent surgical resection 53 Systolic Blood Pressure 53 HBeAg seroconversion 53 Viral Load 53 proximal femur 53 T1c 53 Quadrature Phase Shift Keying 53 needle aspiration 53 coronal plane 53 g cm 53 GORE TAG Device 53 sinus node dysfunction 53 MMSE score 53 IU ml 53 μg mL 53 T#/T# 53 τ 53 eplerenone 53 P cadherin 53 deep venous thromboses 53 prostatic 53 ductal cancer 53 aggregated Abeta 53 gastric cardia 53 Neovascularization 53 RNFL thickness 53 tibial nerve 53 #ß 53 ventricular dilatation 53 ileal 53 longus tendon 53 electrophysiologic 53 CIN3 53 euthyroid 53 Secondary endpoints include 53 N telopeptide 53 Cell Receptor 53 aminotransferase ALT 53 radiographically 53 xenograft tumors 53 serum PSA 53 variance ANOVA 53 hydronephrosis 53 Cypher Stent 53 ug ml 53 middle temporal gyrus 53 LC MALDI 53 apolipoprotein B 53 Fig. 3A 53 Akt phosphorylation 53 osteoid 53 calcaneal fractures 53 5 hydroxytryptamine 53 osteoblastic 53 SGOT 53 myeloperoxidase 53 dimensional computed tomography 53 -#.# log# 53 AUC0 53 hindlimb 53 histopathologic findings 53 pg mL 53 aortic regurgitation 53 hydroxyproline 53 corticosteroid dose 53 virologic responses 53 isoprostanes 53 interleukin IL 53 Mol Med 53 incontinence episodes 53 subtrochanteric 53 peri implant 53 Index CDAI score 53 anterior uveitis 53 genotypic resistance 53 tertile 53 cough dyspnea 53 Febrile neutropenia 53 Adjuvant Treatment 53 FiO 53 kg/m3 53 Immunohistochemical analysis 53 ,#,# [002] 53 HCV Genotype 53 corneal astigmatism 53 hepatic resection 53 Bankart lesion 53 plasminogen activator inhibitor 53 antibody titer 53 intraclass correlation coefficient 53 normothermic 53 extrahepatic 53 luminal 53 NIS LL 53 supraclavicular 53 Tasigna prolongs 53 rebleeding 53 LVEF 53 hyperemia 53 ^ F FDG 53 endothelial activation 53 Ishak fibrosis score 53 relapsed MM 53 vertebrobasilar 53 Alzheimer Disease Assessment 53 osteoconductive 53 distal radius 53 lymphadenopathy 53 x ULN 53 #nm #nm [001] 53 docetaxel pretreated 53 Clinical Outcome 53 S#B [002] 53 methacholine challenge 53 sympathectomy 53 osteochondral lesions 53 gyri 53 CIN3 + 53 mg BID dose 53 multivariable logistic regression 53 extensor mechanism 53 CORE OM 53 cannulated screws 53 Eur Respir J 53 histologic 53 ductus venosus 53 macular thickness 53 #ng/ml 53 Fig. 1c 53 Leukocyte 53 #PD 53 pulmonary arterial 53 rearfoot 53 iPTH 53 focally 53 ethmoid 53 recurrent venous thromboembolism 53 gastric adenocarcinoma 53 node metastases 53 plasma cortisol 53 Pressure Transducer 53 Severity MSCS score 53 Linearity 53 magnification x# [002] 53 gauge vitrectomy